1. Home
  2. LSTA vs FTHM Comparison

LSTA vs FTHM Comparison

Compare LSTA & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • FTHM
  • Stock Information
  • Founded
  • LSTA 1980
  • FTHM 2010
  • Country
  • LSTA United States
  • FTHM United States
  • Employees
  • LSTA N/A
  • FTHM N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • FTHM Real Estate
  • Sector
  • LSTA Health Care
  • FTHM Finance
  • Exchange
  • LSTA Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • LSTA 20.0M
  • FTHM 21.0M
  • IPO Year
  • LSTA N/A
  • FTHM 2020
  • Fundamental
  • Price
  • LSTA $2.18
  • FTHM $1.24
  • Analyst Decision
  • LSTA Strong Buy
  • FTHM Buy
  • Analyst Count
  • LSTA 1
  • FTHM 1
  • Target Price
  • LSTA $15.00
  • FTHM $2.50
  • AVG Volume (30 Days)
  • LSTA 10.9K
  • FTHM 42.4K
  • Earning Date
  • LSTA 05-08-2025
  • FTHM 05-13-2025
  • Dividend Yield
  • LSTA N/A
  • FTHM N/A
  • EPS Growth
  • LSTA N/A
  • FTHM N/A
  • EPS
  • LSTA N/A
  • FTHM N/A
  • Revenue
  • LSTA $1,000,000.00
  • FTHM $357,816,000.00
  • Revenue This Year
  • LSTA N/A
  • FTHM $29.10
  • Revenue Next Year
  • LSTA N/A
  • FTHM $20.74
  • P/E Ratio
  • LSTA N/A
  • FTHM N/A
  • Revenue Growth
  • LSTA N/A
  • FTHM 5.80
  • 52 Week Low
  • LSTA $1.87
  • FTHM $0.65
  • 52 Week High
  • LSTA $4.20
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 44.79
  • FTHM 75.44
  • Support Level
  • LSTA $2.07
  • FTHM $0.79
  • Resistance Level
  • LSTA $2.46
  • FTHM $0.92
  • Average True Range (ATR)
  • LSTA 0.17
  • FTHM 0.08
  • MACD
  • LSTA -0.02
  • FTHM 0.04
  • Stochastic Oscillator
  • LSTA 22.92
  • FTHM 95.54

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

Share on Social Networks: